HPLC and HPLC-MS Analysis of Intestinal Elimination and Phase 2 Metabolism of 4'-hydroxy-4-Methoxychalcone and its Bis-Mannich Analog In The Rat

Aline Bernardes1, 2, Mónika Kuzma2, 3, Attila Almási2, Mátyás Mayer3, Caridad Noda Pérez4, Pál Perjési2, *
1 Federal Institute of Education, Science and Technology of Mato Grosso, Cuiabá, Brazil
2 Institute of Pharmaceutical Chemistry, University of Pécs, Pécs, Hungary
3 Institute of Forensic Medicine, University of Pécs, Pécs, Hungary
4 Institute of Chemistry, Federal University of Goiás, Goiânia, Brazil

Article Metrics

CrossRef Citations:
Total Statistics:

Full-Text HTML Views: 762
Abstract HTML Views: 259
PDF Downloads: 412
ePub Downloads: 184
Total Views/Downloads: 1617
Unique Statistics:

Full-Text HTML Views: 331
Abstract HTML Views: 193
PDF Downloads: 205
ePub Downloads: 135
Total Views/Downloads: 864

Creative Commons License
© 2022 Bernardes et al.

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

* Address correspondence to this author at the Department of Pharmaceutical Chemistry University of Pecs, Postal address: H-7624 Pécs, Rókus u. 2, Hungary; Tel: +36 72 503 626; Fax: +36 72 503 627; E-mail:



The aim was to study the elimination and Phase 2 biotransformation of 4'-hydroxy-4-methoxychalcone (1) and its bis-Mannich analog (2) in the small intestine of the rat.


Earlier studies indicated that chalcones are promising starting points for drug design. Aminomethylation of drugs is considered to improve their delivery into the human body.


To set up validated HPLC-UV methods to quantitate the investigated chalcones in the rat intestinal perfusates. Comparison of intestinal disappearance and Phase 2 metabolic profile of the 4’-hydroxychalcone (1) and a bis-Mannich analog (2).


Chalcones 1 and 2 were luminally perfused in the small intestine of rats at a concentration of 240 μM and 280 μM, respectively. Analysis of the collected intestinal perfusate samples was performed by a validated HPLC-UV method. Using HPLC-MS, the samples were analyzed for Phase 2 metabolites as well.


Elimination kinetics of the two 4’-hydroxychalcones displayed characteristic differences having the nonpolar chalcone 1 higher elimination rate over the 90-minute ex vivo experiments. HPLC-MS analysis of the perfusates indicated the presence of glucuronide, sulfate, and glutathione conjugates in the parent molecules. Intestinal disappearance and sulfation of the bis-Mannich derivative 2 showed characteristic differences compared to 1


The results demonstrate, to the best of our knowledge, for the first time, how the title structural modification of phenolic chalcones affects intestinal elimination and Phase 2 metabolism of the compounds


Study on ex vivo intestinal elimination of a 4'-hydroxy-4-methoxychalcone and its bis-Mannich analog.

Development of validated HPLC-UV methods for quantitation of 4’-hydroxychalcone derivatives in rat intestinal perfusates.

HPLC-MS identification of Phase 2 metabolites of 4’-hydroxychalcones in rat intestinal perfusates.

Keywords: Hydroxychalcones, Mannich bases, HPLC, HPLC-MS, Intestinal absorption, Intestinal metabolism.